Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanfei Qiu

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
European Journal of Medicinal Chemistry|February 7, 2021
Synthesis, biological evaluation and structure-activity relationship of novel dichloroacetophenones targeting pyruvate dehydrogenase kinases with potent anticancer activityBiao Xu, Zhi-Peng Wang, Qingwang Liu, et al.
Journal of Medicinal Chemistry|May 25, 2022
Optimization of the Natural Product Calothrixin A to Discover Novel Dual Topoisomerase I and II Inhibitors with Improved Anticancer ActivityXiaohong Yang, Zhi-Peng Wang, Sichuan Xiang, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
TH5487 specifically targets NLRP3 in FCAS patients resistant to MCC950Angela Lackner, Lemuel Leonidas, Alijah Macapagal, et al.
Communications Biology|April 16, 2026
TH5487 specifically targets NLRP3 in FCAS patients resistant to MCC950Angela Lackner, Sofia I Picucci, Wenjin Jiang, et al.
Journal of Epidemiology|December 8, 2024
Colorectal Cancer Screening Based on Fecal Immunochemical Test and Risk Assessment: A Population-based Study Including Two Million Participants in ChinaDong Hang, Chen Zhu, Xiaolin Yang, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
European Journal of Medicinal Chemistry|February 7, 2021
Synthesis, biological evaluation and structure-activity relationship of novel dichloroacetophenones targeting pyruvate dehydrogenase kinases with potent anticancer activityBiao Xu, Zhi-Peng Wang, Qingwang Liu, et al.
Journal of Medicinal Chemistry|May 25, 2022
Optimization of the Natural Product Calothrixin A to Discover Novel Dual Topoisomerase I and II Inhibitors with Improved Anticancer ActivityXiaohong Yang, Zhi-Peng Wang, Sichuan Xiang, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
TH5487 specifically targets NLRP3 in FCAS patients resistant to MCC950Angela Lackner, Lemuel Leonidas, Alijah Macapagal, et al.
Communications Biology|April 16, 2026
TH5487 specifically targets NLRP3 in FCAS patients resistant to MCC950Angela Lackner, Sofia I Picucci, Wenjin Jiang, et al.
Journal of Epidemiology|December 8, 2024
Colorectal Cancer Screening Based on Fecal Immunochemical Test and Risk Assessment: A Population-based Study Including Two Million Participants in ChinaDong Hang, Chen Zhu, Xiaolin Yang, et al.
Pageof 2